Recruiting for Research Study: THRIVE (Targeting Health and Resilience for Individuals with a Vulnerable Eating History)
Do you have a history of an eating disorder or eating problems and are currently in your first or second trimester of pregnancy?
PPD Screening and Treatment: Is There Room for Improvement? A New Study at Mass General Brigham
Announcing a new CWMH study on postpartum depression screening and treatment outcomes at Mass General Brigham.
New Research Study: Family-Based Intervention to Reduce Anxiety in 2- to 3-Year-Old Children Â
Anxiety disorders affect as many as 30% of children and adolescents, and the children of parents with an anxiety disorder have a higher risk of developing an anxiety disorder than the children of parents [...]
What We Are Learning From the MGH Postpartum Psychosis Project
Postpartum psychosis (PPP) is a serious psychiatric illness, occurring in 1 to 2 per 1000 women in the weeks. Â Because postpartum psychosis is relatively uncommon, we do not have specific guidelines regarding its treatment. [...]
New Study at CWMH: Depression and Obsessive Compulsive Symptoms During the Postpartum Period
Recent studies have shown that pregnancy and childbirth are frequently associated with the onset of Obsessive Compulsive Disorder (OCD). Â While most women do not have the full set of symptoms to meet diagnostic criteria for [...]
Remote Enrollment Initiated in MGH Study Assessing Mood Symptoms Across Infertility Treatment
We are pleased to announce the recent launch of an exciting new research initiative that is being conducted by the Massachusetts General Hospital Center for Women’s Mental Health. The Symptom Tracking in Assisted Reproductive Technologies study (START study) will focus on understanding the risk factors for depressive relapse in women undergoing infertility treatments. There has been a growing request in our clinical work to address the needs of women undergoing infertility treatments.  It is our hope that such a study will provide important information on the course and risk of depression in women undergoing fertility treatment and thus inform clinical care.
Yet Another Study Investigating SSRIs and Their Impact on Neonatal Outcomes
In a recent retrospective cohort study, data collected from linked records from the Women's and Children's Health Network in South Australia were used to investigate neonatal outcomes in children exposed prenatally to selective serotonin reuptake inhibitors (SSRIs). Women were included in this study if they gave birth to a singleton, live-born infant between September 2000 and December 2008 (n = 33,965).
SSRIs and Adverse Pregnancy Outcomes: Why You Can’t Just Read the Abstract
Over the past few years, there have been a large number of studies which have relied on large administrative databases to generate information on the reproductive safety of various medications. One of the strengths of this type of approach is that it provides an opportunity to observe outcomes in a large number of subjects; however, there are certain, very important limitations. A recent study published in the American Journal of Obstetrics and Gynecology helps to understand some of the challenges in interpreting the data generated from these studies.
New Research Study at CWMH: Treatment of Premenstrual Worsening of Depression
Seeking women between 18-45 with PMS who have been diagnosed with depression. If you are between 18 and 45 and: